These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18430260)

  • 1. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
    Georgescu MM; Cote G; Agarwal NK; White CL
    Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
    Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
    EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
    Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
    Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of NHERF1/EBP50 in cancer.
    Georgescu MM; Morales FC; Molina JR; Hayashi Y
    Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
    Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
    Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
    Li H; Zhang B; Liu Y; Yin C
    Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
    Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
    Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
    Sun J; Li P; Yang J
    Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
    Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
    Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
    Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
    Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1.
    Li J; Callaway DJ; Bu Z
    J Mol Biol; 2009 Sep; 392(1):166-80. PubMed ID: 19591839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle.
    Pera T; Tompkins E; Katz M; Wang B; Deshpande DA; Weinman EJ; Penn RB
    FASEB J; 2019 Aug; 33(8):9008-9016. PubMed ID: 31042404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.